Corporate Profile

InterCure is the leading, fastest growing and the most profitable Israeli cannabis company. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to be the most profitable cannabis company globally outside of North America.

InterCure is listed on the Toronto Stock Exchange under the symbol INCR.U and trades on the Tel Aviv Stock Exchange under the symbol INCR.TA. Listing of InterCure’s Shares on NASDAQ Expected in Q2 2021 and Will Trade Under the Symbol “INCR”.


lnk Overview

Read More

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

lnk Stock Information

View All Stock Information

Corporate Governance

lnk Governance

Investor events will be posted soon.

lnk Events

View All Events
Featured Reports
Featured Reports will be posted here.